Pilot dose-response trial of i.v. ketamine in treatment-resistant depression.
about
Ketamine and Beyond: Investigations into the Potential of Glutamatergic Agents to Treat Depression.Ketamine for depression: evidence, challenges and promiseNovel Glutamatergic Treatments for Severe Mood Disorders.Effects of Low-Dose and Very Low-Dose Ketamine among Patients with Major Depression: a Systematic Review and Meta-Analysis.Ninety-six hour ketamine infusion with co-administered clonidine for treatment-resistant depression: A pilot randomised controlled trial.Single-dose infusion ketamine and non-ketamine N-methyl-d-aspartate receptor antagonists for unipolar and bipolar depression: a meta-analysis of efficacy, safety and time trajectories.Strategies to mitigate dissociative and psychotomimetic effects of ketamine in the treatment of major depressive episodes: a narrative review.KETAMINE FOR TREATMENT-RESISTANT UNIPOLAR AND BIPOLAR MAJOR DEPRESSION: CRITICAL REVIEW AND IMPLICATIONS FOR CLINICAL PRACTICE.Comments on Cooper et al.'s review on strategies to mitigate dissociative and psychotomimetic effects from ketamine when used as a fast-acting antidepressant.Glutamate-Based Drug Discovery for Novel Antidepressants.The use of ketamine in ECT anaesthesia: A systematic review and critical commentary on efficacy, cognitive, safety and seizure outcomes.Placebo-controlled pilot trial testing dose titration and intravenous, intramuscular and subcutaneous routes for ketamine in depression.Long-Term Ketamine Self-Injections in Major Depressive Disorder: Focus on Tolerance in Ketamine's Antidepressant Response and the Development of Ketamine Addiction.Effect of ketamine dose on self-rated dissociation in patients with treatment refractory anxiety disorders.Ketamine and Ketamine Metabolite Pharmacology: Insights into Therapeutic Mechanisms.
P2860
Q34551188-ED3D5D1D-85A2-47DC-8485-E11A5D7C8384Q36118741-9BFACD45-BF51-43A9-B5D6-9DB4049C3748Q36498659-62C3B031-CA07-4AB0-812F-4B83E54032D0Q36852411-4FB2DFCE-176F-4389-B998-5F0EDF3CC414Q36998808-C80B44C8-A578-4BBF-8987-E3481E01263AQ37424333-C2D3C2DD-E0DE-42BC-9BF3-B2DD7F91623BQ38692317-0FEDBAE1-407E-428F-97D2-71BEDE56A1F3Q38803429-7F12BCB5-A60C-4124-9F9B-844A084CA9CFQ38846034-BEBAD48D-7A08-491B-BD3D-296C70DC031AQ38895017-EEC1E457-FBA1-4D37-8502-BC24AE6C5FA1Q39021973-F5FF656D-E629-42B2-9B21-2064F5FB496BQ47447132-0C425425-7188-40A2-B614-B1229E7A6B4BQ47658882-D9822D17-D4B5-4AB2-B4EC-035A3F629C85Q47689382-FDFB9EB7-7B73-493B-9F62-8FF60E9E823EQ55438088-1A641044-2B6D-4892-B4CA-9E42E9DA9B7F
P2860
Pilot dose-response trial of i.v. ketamine in treatment-resistant depression.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh-hant
name
Pilot dose-response trial of i.v. ketamine in treatment-resistant depression.
@en
Pilot dose-response trial of i.v. ketamine in treatment-resistant depression.
@nl
type
label
Pilot dose-response trial of i.v. ketamine in treatment-resistant depression.
@en
Pilot dose-response trial of i.v. ketamine in treatment-resistant depression.
@nl
prefLabel
Pilot dose-response trial of i.v. ketamine in treatment-resistant depression.
@en
Pilot dose-response trial of i.v. ketamine in treatment-resistant depression.
@nl
P2093
P2860
P1476
Pilot dose-response trial of i.v. ketamine in treatment-resistant depression.
@en
P2093
Andrew A Somogyi
John Leyden
Natalie Katalinic
Rosalyn Lai
Simon Harper
P2860
P304
P356
10.3109/15622975.2014.922697
P577
2014-06-09T00:00:00Z